A randomized trial to evaluate the pharmacokinetics, pharmacodynamics, and safety of vadadustat in patients with anemia associated with chronic kidney disease receiving hemodialysis
ClinicalTrials.gov ID NCT03992066; https://clinicaltrials.gov/study/NCT03992066 ; Retrospectively registered on June 18, 2019. Accessed January 13, 2025.
Authors
- Steven K. Burke (ORCID: https://orcid.org/0000-0002-9073-0239)
- Ajit Chavan
- Wang Don
- Pamela Navarro‐Gonzales (ORCID: https://orcid.org/0009-0007-1204-8246)
- Kevin Dykstra (ORCID: https://orcid.org/0009-0001-9521-038X)
Institutions
- Akebia Therapeutics (United States) (US)
Publication Details
- Journal
- BMC Nephrology
- Published
- 2025-08-11
- DOI
- https://doi.org/10.1186/s12882-025-04367-x
- Primary Topic
- Erythropoietin and Anemia Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Akebia Therapeutics